A specialty pharmaceutical and medical device company that discovers, develops and markets innovative technologies and medical products for local diseases, and for other complications.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
Angiotech Pharmaceuticals, Inc. is a specialty pharmaceutical and medical device company that discovers, develops and markets technologies primarily focused on acute and surgical applications. The Company generates its revenue through the sales of medical products and components, as well as from royalties derived from sales by its partners of products utilizing certain of its own technologies. The Company operates in two segments: Pharmaceutical Technologies and Medical Products. The Pharmaceuticals Technologies segment includes royalty revenue and gross margin generated from out-licensing technology related to the drug-eluting stent and other technologies. As of December 31, 2007, the Company’s principal revenues in this segment come from royalties derived from sales by Boston Scientific Corporation (BSC) of TAXUS coronary stent systems incorporating the drug paclitaxel. The Medical Products segment includes revenues and gross margins of single use, specialty medical devices.